Evoke plc (LON:EVOK - Get Free Report) rose 1.8% on Tuesday . The company traded as high as GBX 57.50 ($0.77) and last traded at GBX 57.40 ($0.77). Approximately 1,049,712 shares traded hands during mid-day trading, a decline of 51% from the average daily volume of 2,143,170 shares. The stock had previously closed at GBX 56.40 ($0.76).
Evoke Stock Up 1.8%
The stock has a market cap of £256.00 million, a price-to-earnings ratio of -1.43 and a beta of 0.84. The company's 50-day moving average is GBX 52.04 and its 200-day moving average is GBX 60.05.
Evoke (LON:EVOK - Get Free Report) last issued its earnings results on Wednesday, March 26th. The company reported GBX (6.40) (($0.09)) earnings per share (EPS) for the quarter. Evoke had a negative return on equity of 517.98% and a negative net margin of 8.50%. On average, research analysts forecast that Evoke plc will post 12.7648305 earnings per share for the current year.
Insiders Place Their Bets
In related news, insider Per Widerström bought 68,958 shares of the company's stock in a transaction on Friday, May 23rd. The stock was bought at an average cost of GBX 54 ($0.72) per share, with a total value of £37,237.32 ($49,989.69). Also, insider Sean Wilkins bought 31,659 shares of Evoke stock in a transaction dated Friday, May 23rd. The shares were bought at an average price of GBX 54 ($0.72) per share, for a total transaction of £17,095.86 ($22,950.54). Over the last ninety days, insiders have bought 402,269 shares of company stock valued at $20,115,918. 27.00% of the stock is currently owned by insiders.
Evoke Company Profile
(
Get Free Report)
Featured Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Evoke, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Evoke wasn't on the list.
While Evoke currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.